Rémi Delansorne
Keine laufenden Positionen mehr
Profil
Rémi Delansorne served as the Chief Executive Officer & Director at Hybrigenics SA from 2007 to 2017.
Prior to that, he worked at Hybrigenics SA from 2004 to 2020.
He also worked as the Head-Diabetes Research at Merck Serono Ltd.
Dr. Delansorne holds a doctorate degree from Université Pierre et Marie Curie and a doctorate degree from École Nationale Vétérinaire d'Alfort.
Ehemalige bekannte Positionen von Rémi Delansorne
| Unternehmen | Position | Ende |
|---|---|---|
| ATON | Chief Executive Officer | 12.03.2020 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Rémi Delansorne
| École Nationale Vétérinaire d'Alfort | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATON | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
